If you’re on a GLP-1 and not getting the results everyone else is talking about, this episode is for you.Today we’re breaking down the future of obesity and metabolic care: NuSH (nutrient-stimulated hormone therapy) and OMM (obesity management medications) the next era of treatment for chronic obesity and metabolic health.I walk through my own story of being a true “non-responder” to Ozempic and Trulicity, and how everything changed when I finally found the right mechanism with Mounjaro. And then we zoom out into what’s coming next: multi-hormone therapies, triple agonists, amylin-based options, oral OMM meds, and the new brain-targeted treatments designed to help people whose bodies simply didn’t click with current medications.We also talk about the real-world side of all this; insurance cuts, AI-driven prior auth denials, employer carve-outs, compounding, telehealth access, and the shift toward treating obesity as a true chronic metabolic disease.If you’re feeling discouraged, stuck, or scared your medication isn’t working… you are not broken. You might just be early in the story. And the next chapter of GLP-1 and OMM care is being built for people exactly like you.Start with Fridays (my telehealth partner):👉 https://www.joinfridays.com/?via=carrieExplore GLP-1 with licensed U.S. providers: no insurance required, transparent pricing, and real medical care without judgment. If you're listening before December 4th you can use code DOSEBF to take advantage of the Cyber Monday special or after that code DOSE will still give you a savings. Access all my resources in one place:👉 https://beacons.ai/theelevateddoseGLP-1 info, Custom GPT's, my favorite products, Substack, Facebook group, and more.Subscribe on Substack for deep-dives & weekly education:👉 https://theelevateddose.substack.com

Ver todos los episodios